Overview

A Clinical Study of SPH7854 Granules in Healthy Subjects.

Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety of SPH7854 in healthy subjects.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd